In fiscal year 2025, AHN-GOOK PHARMACEUTICAL (001540) reported revenue of 306.9 billion KRW.
Income Statement
| Year | Revenue | Op Profit | Net Income | Source |
|---|---|---|---|---|
| 2025 | 306.9 billion KRW | 9.8 billion KRW | 7.3 billion KRW | [source] |
| 2024 | 271.1 billion KRW | 6.7 billion KRW | 16.3 billion KRW | [source] |
| 2023 | 233.7 billion KRW | 5.1 billion KRW | 998 million KRW | [source] |
| 2022 | 205.4 billion KRW | 9.7 billion KRW | 6.9 billion KRW | [source] |
| 2021 | 163.5 billion KRW | -1.1 billion KRW | 3.7 billion KRW | [source] |
Balance Sheet
| Year | Total Assets | Total Liabilities | Total Equity | Source |
|---|---|---|---|---|
| 2025 | 296.0 billion KRW | 138.8 billion KRW | 157.1 billion KRW | [source] |
| 2024 | 289.9 billion KRW | 133.4 billion KRW | 156.6 billion KRW | [source] |
| 2023 | 226.8 billion KRW | 82.2 billion KRW | 144.6 billion KRW | [source] |
| 2022 | 206.6 billion KRW | 62.5 billion KRW | 144.2 billion KRW | [source] |
| 2021 | 206.9 billion KRW | 59.2 billion KRW | 147.6 billion KRW | [source] |
